BG Group Plc (BRGYY: OTCQX International Premier) |

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
BG Group Plc (BRGYY: OTCQX International Premier) | Agreement to sell interest in CATS pipeline & infrastructure for £562m

BG Group today announced it had agreed to the sale of its equity interest in the Central Area Transmission System (CATS) gas pipeline in the UK North Sea and associated infrastructure to Antin Infrastructure Partners for total proceeds up to  ? 562 million, or approximately $954 million at current exchange rates.

 

Under the agreement, BG Group will sell its 62.78% interest in CATS for a consideration comprising  ? 523 million (approximately $888 million) on completion of the transaction and a deferred amount of  ? 39 million (approximately $66 million).

 

The sale does not impact BG Group's rights to capacity in CATS.

 

CATS comprises a fixed-riser platform linked to the Everest oil and gas platform, a 404-kilometre,
1 700 million-standard-cubic-feet-of-gas-per-day (mmscfd) capacity subsea pipeline and a two-train onshore gas processing terminal at Teesside which has capacity of 1 200 mmscfd.

 

It is anticipated the transaction will close in the second half of 2014.

 

The sale of CATS is expected, on completion, to create a post-tax profit on disposal of approximately $700 million. This may be partly offset by a potential impairment of BG Group's associated UK North Sea assets following the categorisation of the Group's interest in CATS as held for sale in the second quarter.

 

The sale of the CATS interest is in line with BG Group's strategy to actively manage its asset portfolio and deliver value to shareholders.

 

-ends-

 

Notes to Editors:

BG Group plc (LSE: BG.L) is a world leader in natural gas, with a broad portfolio of business interests focused on exploration and production and liquefied natural gas. Active in more than 20 countries on five continents, BG Group combines a deep understanding of gas markets with a proven track record in finding and commercialising reserves. For further information visit:   www.bg-group.com    

 

There are matters set out within this announcement that are forward-looking statements. Such statements are only predictions, and actual events or results may differ materially. For a discussion of important factors which could cause actual results to differ from these forward-looking statements, refer to
BG Group's Annual Report and Accounts for the year ended 31 December 2013. BG Group does not undertake any obligation to update publicly, or revise, forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent legally required.

                     

Contact:

Mark Todd:                               +44 (0) 118 929 3110           mark.todd@bg-group.com

Kim Blomley:                            +44 (0) 118 938 6568             kim.blomley@bg-group.com

Out of Hours Media Mobile :  +44 (0) 7917 185 707

Investor Relations:                  +44 (0) 118 929 3025           invrel@bg-group.com

 

Social media channels:

Flickr                                      flickr.com/bggroup

Twitter                                    twitter.com/BGGroup

You Tube                               youtube.com/bggroupofficial

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 3

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 4

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Timur Turlov Leads FIDE with Chess and Digital Focus

Updated Category News Views 5

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 4

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 4

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading
Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 9

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading
China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 4

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading
Farm Aid 2026: A Resilient Tribute to Family Farmers

Updated Category News Views 10

Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 5

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 4

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading

Top 5 Most Recently Viewed Articles

Fresh Tracks Therapeutics Completes Strategic Dissolution Steps

Updated Category News Views 324

Fresh Tracks Therapeutics Moving Forward with Dissolution Plans Fresh Tracks Therapeutics, Inc. (FRTX) is actively working through a plan for dissolution, which includes steps to distribute initial cash to its shareholders. In recent statements from the company, they announced that they intend to file a Certificate of Dissolution, which will finalize on a specified date....

Continue Reading
Elkem Secures Support from Norwegian Authorities on Emission Allowances

Updated Category News Views 247

Elkem ASA Receives Positive Conclusion from Norwegian Authorities Elkem ASA, a prominent provider of advanced silicon-based materials, has recently received a crucial affirmation from the Norwegian Ministry of Climate and Environment. The ministry's findings reveal a significant disparity in the allocation of free emission allowances under the EU Emissions Trading System...

Continue Reading
Market Trends: Corporate Bonds and Federal Rates Analysis

Updated Category News Views 338

Investors Turn to Corporate Bonds Amid Economic Changes In recent days, we’ve noticed that investors are increasingly directing funds toward corporate bonds. This shift is particularly notable as risk premiums steadily decline due to the Federal Reserve's recent decision to lower interest rates. This has sparked a renewed sense of optimism that we might sidestep a...

Continue Reading
China's Recent Stimulus Measures: A Key to Economic Revival

Updated Category News Views 154

China's recent economic stimulus measures, unveiled amidst rising deflationary pressures, marked a crucial pivot in the country's financial strategy. With the economy losing momentum, these moves are seen as an essential lifeline. Analysts highlight that this isn't just window dressing; we're talking about substantial fiscal spending and monetary stimulus that far exceed...

Continue Reading
Curasight Reveals Promising Findings from uTREAT Phase 1 Trial

Updated Category News Views 95

Curasight's Promising Launch in Oncology Curasight A/S, a pioneering clinical-stage radiopharmaceutical company, has recently announced exciting preliminary results from their Phase 1 clinical trial evaluating uTREAT, a novel therapeutic option specifically designed for high-grade gliomas. This groundbreaking approach highlights the company’s commitment to advancing...

Continue Reading